Rituximab in newly diagnosed stage IA nodular lymphocyte-predominant Hodgkin lymphoma: long-term follow-up of a phase 2 study from the German Hodgkin Study Group

被引：19
|
作者：
Eichenauer, Dennis A. [1 ,2 ]
Pluetschow, Annette [1 ,2 ]
Fuchs, Michael [1 ,2 ]
Hartmann, Sylvia [3 ]
Hansmann, Martin-Leo [3 ]
Boell, Boris [1 ,2 ]
von Tresckow, Bastian [1 ,2 ]
Borchmann, Peter [1 ,2 ]
Engert, Andreas [1 ,2 ]
机构：
[1] Univ Cologne, Ctr Integrated Oncol Aachen Bonn Cologne Dusseldo, Dept Internal Med 1, Cologne, Germany
[2] Univ Hosp Cologne, GHSG, Cologne, Germany
[3] Univ Hosp Frankfurt, Senckenberg Inst Pathol, Frankfurt, Germany
来源：
LEUKEMIA | 2020年 / 34卷 / 03期
关键词：
D O I：
10.1038/s41375-019-0609-3
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：953 / 956
页数：4
相关论文
共 50 条
  • [1] Rituximab in newly diagnosed stage IA nodular lymphocyte-predominant Hodgkin lymphoma: long-term follow-up of a phase 2 study from the German Hodgkin Study Group
    Dennis A. Eichenauer
    Annette Plütschow
    Michael Fuchs
    Sylvia Hartmann
    Martin-Leo Hansmann
    Boris Böll
    Bastian von Tresckow
    Peter Borchmann
    Andreas Engert
    Leukemia, 2020, 34 : 953 - 956
  • [2] Phase 2 study of rituximab in newly diagnosed stage IA nodular lymphocyte-predominant Hodgkin lymphoma: a report from the German Hodgkin Study Group
    Eichenauer, Dennis A.
    Fuchs, Michael
    Pluetschow, Annette
    Klimm, Beate
    Halbsguth, Teresa
    Boell, Boris
    Von Tresckow, Bastian
    Nogova, Lucia
    Borchmann, Peter
    Engert, Andreas
    BLOOD, 2011, 118 (16) : 4363 - 4365
  • [3] Phase II Study of Rituximab in Newly Diagnosed Stage IA Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL): A Report From the German Hodgkin Study Group (GHSG)
    Eichenauer, Dennis A.
    Fuchs, Michael
    Pluetschow, Annette
    Klimm, Beate
    Halbsguth, Teresa
    Boell, Boris
    von Tresckow, Bastian
    Borchmann, Peter
    Engert, Andreas
    BLOOD, 2011, 118 (21) : 1166 - 1167
  • [4] Long-Term Course of Patients With Stage IA Nodular Lymphocyte-Predominant Hodgkin Lymphoma: A Report From the German Hodgkin Study Group
    Eichenauer, Dennis A.
    Pluetschow, Annette
    Fuchs, Michael
    von Tresckow, Bastian
    Boell, Boris
    Behringer, Karolin
    Diehl, Volker
    Eich, Hans Theodor
    Borchmann, Peter
    Engert, Andreas
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (26) : 2857 - +
  • [5] Treatment of Stage IA Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL): An Analysis from the German Hodgkin Study Group (GHSG)
    Eichenauer, Dennis A.
    Pluetschow, Annette
    Fuchs, Michael
    Behringer, Karolin
    Boell, Boris
    von Tresckow, Bastian
    Diehl, Volker
    Borchmann, Peter
    Engert, Andreas
    BLOOD, 2014, 124 (21)
  • [6] Rituximab in relapsed lymphocyte-predominant Hodgkin lymphoma:: long-term results of a phase 2 trial by the German Hodgkin Lymphoma Study Group (GHSG)
    Schulz, Holger
    Rehwald, Ute
    Morschhauser, Franck
    Elter, Thomas
    Driessen, Christoph
    Ruediger, Thomas
    Borchmann, Peter
    Schnell, Roland
    Diehl, Volker
    Engert, Andreas
    Reiser, Marcel
    BLOOD, 2008, 111 (01) : 109 - 111
  • [7] RITUXIMAB PLUS ABVD IN NEWLY DIAGNOSED NODULAR LYMPHOCYTE-PREDOMINANT HODGKIN LYMPHOMA
    Cencini, E.
    Fabbri, A.
    Lazzi, S.
    Leoncini, L.
    Bocchia, M.
    HAEMATOLOGICA, 2015, 100 : 152 - 152
  • [8] Rituximab plus ABVD in newly diagnosed nodular lymphocyte-predominant Hodgkin lymphoma
    Cencini, Emanuele
    Fabbri, Alberto
    Bocchia, Monica
    BRITISH JOURNAL OF HAEMATOLOGY, 2017, 176 (05) : 831 - 833
  • [9] Ofatumumab in relapsed nodular lymphocyte-predominant Hodgkin lymphoma: results of a phase II study from the German Hodgkin study group
    D A Eichenauer
    H Goergen
    A Plütschow
    D Wongso
    K Behringer
    S Kreissl
    I Thielen
    T Halbsguth
    P J Bröckelmann
    M Fuchs
    B Böll
    B von Tresckow
    P Borchmann
    A Engert
    Leukemia, 2016, 30 : 1425 - 1427
  • [10] Relapsed Nodular Lymphocyte-Predominant Hodgkin Lymphoma: An Analysis from the German Hodgkin Study Group (GHSG)
    Eichenauer, Dennis A.
    Pluetschow, Annette
    Schroeder, Lena
    Fuchs, Michael
    von Tresckow, Bastian
    Diehl, Volker
    Borchmann, Peter
    Engert, Andreas
    BLOOD, 2016, 128 (22)
12345